These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Effect of dose and formulation on iron tolerance in pregnancy. Shatrugna V, Raman L, Kailash U, Balakrishna N, Rao KV. Natl Med J India; 1999; 12(1):18-20. PubMed ID: 10326325 [Abstract] [Full Text] [Related]
7. [Bioavailability of Ce-Ferro forte. Comparative iron load test (author's transl)]. Richter E, Schmitt B, Zilly W. Med Klin; 1978 Aug 25; 73(34):1171-5. PubMed ID: 683118 [Abstract] [Full Text] [Related]
8. Relative bioavailability of iron from two different iron tablets used in the Indonesian Iron Supplementation Program. Thorand B, Pietzik K, Dillon D, Schultink W, Gross R. Southeast Asian J Trop Med Public Health; 1993 Dec 25; 24(4):624-30. PubMed ID: 7939931 [Abstract] [Full Text] [Related]
9. Study of bioavailability of oral iron preparations. Gupta KC, Paul T, Mehta JM, Desai NK, Sanghvi B, Sheth UK. J Postgrad Med; 1976 Apr 25; 22(2):94-9. PubMed ID: 802126 [No Abstract] [Full Text] [Related]
11. Poor clinical response to enteric-coated iron preparations. Rudinskas L, Paton TW, Walker SE, Dotten DA, Cowan DH. CMAJ; 1989 Sep 15; 141(6):565-6. PubMed ID: 2776097 [No Abstract] [Full Text] [Related]
12. Adverse effects of iron supplementation: a comparative trial of a wax-matrix iron preparation and conventional ferrous sulfate tablets. Brock C, Curry H, Hanna C, Knipfer M, Taylor L. Clin Ther; 1985 Sep 15; 7(5):568-73. PubMed ID: 4053146 [Abstract] [Full Text] [Related]
13. Iron resorption after gastrectomy and Tardyferon treatment. Heinrich HC, Gabbe EE. Med Klin; 1979 Aug 24; 74(34):1225-7. PubMed ID: 502955 [No Abstract] [Full Text] [Related]
14. Equivalent bioavailability of iron from ferrous salts and a ferric polymaltose complex. Clinical and experimental studies. Jacobs P. Arzneimittelforschung; 1987 Jan 24; 37(1A):113-6. PubMed ID: 3566865 [Abstract] [Full Text] [Related]
15. [Resorption of oral iron preparations]. Heinrich HC, Führ J. Med Welt; 1980 Jul 25; 31(29-30):1104-5. PubMed ID: 7412541 [No Abstract] [Full Text] [Related]
17. Comparative assessment of the bioavailability, efficacy and safety of a modified-release (MR) carbonyl iron tablet and oral conventional iron preparation in adult Indian patients with nutritional iron deficiency anaemia. Adsul BB, Desai A, Gawde A, Baliga V. J Indian Med Assoc; 2005 Jun 25; 103(6):338-42. PubMed ID: 16225161 [Abstract] [Full Text] [Related]
18. Pharmacokinetics of iron salts and ferric hydroxide-carbohydrate complexes. Geisser P, Müller A. Arzneimittelforschung; 1987 Jan 25; 37(1A):100-4. PubMed ID: 3566862 [Abstract] [Full Text] [Related]
19. Absorption and side-effects after peroral administration of sustained release iron tablets. Ferro-Retard compared with Ferronicum and Duroferon Duretter. Levy F, Anderson P, Ekren T. Acta Med Scand; 1978 Jan 25; 204(4):303-10. PubMed ID: 358765 [Abstract] [Full Text] [Related]
20. [Effect of aging on stability and dissolution velocity of controlled-release ferrous sulfate tablets]. Raggi MA, Cavrini V, Di Pietra AM. Boll Chim Farm; 1980 Nov 25; 119(11):663-8. PubMed ID: 7225227 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]